Role of interleukin 1 beta in esophageal squamous cell carcinoma

Journal of Molecular Medicine

Volumn 90, Issue 1, 2012, Pages 89-100

  Chen, Miao Fen ^a,b   Lu, Ming Shian ^a   Chen, Ping Tsung ^a   Chen, Wen Cheng ^a,b   Lin, Paul Yang ^a   Lee, Kuan Der ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Esophageal squamous cell carcinoma; IL 1 beta; NF B; Prognosis; UCP

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; UBIQUITIN CONJUGATING ENZYME E2;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ADULT; AGED; ANIMALS; ANTINEOPLASTIC AGENTS; CAFFEIC ACIDS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; HUMANS; INTERLEUKIN-1BETA; MALE; MICE; MICE, NUDE; MIDDLE AGED; NF-KAPPA B; PHENYLETHYL ALCOHOL; PROGNOSIS; RADIATION TOLERANCE; SURVIVAL ANALYSIS;

EID: 84857364184     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0809-4     Document Type: Article

References (35)

1. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349:2241-2252 (Pubitemid 37485141)
2. Bedenne L, Michel P, Bouche O, Milan C, Mariette C et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160-1168 (Pubitemid 46640561)
3. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H et al (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234:360-367, discussion 368-369
4. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z et al (2006) Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106:552-558 (Pubitemid 43157617)
5. Siewert JR, Ott K (2007) Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol 17:38-44 (Pubitemid 44918361)
6. Wu X, Gu J, Wu TT, Swisher SG, Liao Z et al (2006) Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 24:3789-3798 (Pubitemid 46628477)
7. Nozoe T, Saeki H, Sugimachi K (2001) Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 182:197-201 (Pubitemid 32907362)
8. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89:1028-1030 (Pubitemid 37239206)
9. Gelin J, Moldawer LL, Lonnroth C, Sherry B, Chizzonite R et al (1991) Role of endogenous tumor necrosis factor alpha and interleukin one for experimental tumor growth and the development of cancer cachexia. Cancer Res 51:415-421
10. Strassmann G, Fong M, Freter CE, Windsor S, D'Alessandro F et al (1993) Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. J Clin Invest 92:2152-2159 (Pubitemid 23333518)
11. Smyth MJ, Cretney E, Kershaw MH et al (2004) Cytokines in cancer immunity and immunotherapy. Immunol Rev 202:275-293 (Pubitemid 39576919)
12. Abdel-Latif MM, Duggan S, Reynolds JV, Kelleher D (2009) Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 9:396-404
13. Weber A, Wasiliew P, Kracht M (2010) Interleukin-1 (IL-1) pathway. Sci Signal 3:cm1
14. Arlt A, Vorndamm J, Muerkoster S, Yu H, Schmidt WE et al (2002) Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res 62:910-916 (Pubitemid 34126972)
15. Maihöfner C, CharalambousMP, Bhambra U et al (2003) Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis 24:665-671 (Pubitemid 36592401)
16. Wolf JS, Chen Z, Dong G et al (2001) IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 7:1812-1820 (Pubitemid 32708653)
17. Mukhopadhyay P, Ali MA, Nandi A et al (2006) The cyclin-dependent kinase two inhibitor down-regulates nterleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells. Cancer Res 66:1758-1766 (Pubitemid 43259961)
18. Ito H, Kaneko K, Makino R, Konishi K, Kurahashi T et al (2007) Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol Rep 18:473-481
19. Deans DA, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA et al (2006) Elevated tumour interleukin-1beta is associated with systemic inflammation: a marker of reduced survival in gastrooesophageal cancer. Br J Cancer 95:1568-1575 (Pubitemid 44863361)
20. Wu IC, Lu CY, Kuo FC, Tsai SM, Lee KWet al (2006) Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur J Clin Invest 36:236-241
21. Hu CP, Hsieh HG, Chien KY, Wang PY, Wang CI et al (1984) Biologic properties of three newly established human esophageal carcinoma cell lines. J Natl Cancer Inst 72:577-583
22. Chen MF, Lee KD, Lu MS, Chen CC, Hsieh MJ et al (2009) The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma. J Mol Med 87:307-320
23. Baeuerle PA, Henkel T (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179
24. Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301-310 (Pubitemid 37328783)
25. Wu CS, ChenMF, Lee IL, Tung SY (2007) Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester. J Clin Gastroenterol 41:894-900
26. Yamanaka N, Morisaki T, Nakashima H et al (2004) Interleukin 1beta enhances invasive ability of gastric carcinoma through nuclear factor-kappaB activation. Clin Cancer Res 10:1853-1859 (Pubitemid 38435577)
27. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227
28. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS et al (1999) Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59:2347-2352 (Pubitemid 29242281)
29. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A 93:9090-9095 (Pubitemid 26282023)
30. Chiao C, CarothersAM, Grunberger D, Solomon G, PrestonGA et al (1995) Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells. Cancer Res 55:3576-3583
31. Chen MF, Keng PC, Lin PY, Yang CT, Liao SK et al (2005) Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo. BMC Cancer 5:158
32. Kim MK, Cho KJ, Kwon GY, Park SI, Kim YH et al (2008) ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer. Eur J Cancer 44:54-60 (Pubitemid 350256935)
33. Chen MF, Fang FM, Lu CH, Lu MS, Chen WC et al (2008) Significance of nuclear accumulation of Foxo3a in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 71:1220-1229
34. Brown JM, Attardi LD (2005) The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5:231-237 (Pubitemid 40314954)
35. Olive PL, Banath JP (2004) Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 58:331-335 (Pubitemid 38142456)